Stockreport

Dermata Therapeutics Announces Closing of $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules [Yahoo! Finance]

Dermata Therapeutics, Inc.  (DRMA) 
PDF SAN DIEGO, CA / ACCESSWIRE / September 17, 2024 Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company [Read more]